Organic Growth Amid Challenges
Vitrolife delivered a 5% organic growth in local currencies, excluding discontinued business, despite facing macroeconomic and geopolitical challenges in the reproductive health industry.
Strong Performance in Americas
Sales in the Americas increased by 11% in local currencies with strong growth across the entire portfolio and in all markets, marking the strongest quarter in 11 quarters.
Stable Gross and EBITDA Margins
Gross margin slightly increased to 58.9%, and EBITDA was SEK 253 million, with an EBITDA margin of 30.3%, showing resilience despite negative currency impacts.
Positive Developments in EMEA and APAC
EMEA showed a 4% growth in local currencies, excluding discontinued business, and APAC recorded its first positive quarter of the year with 1% organic growth.
Operational Cash Flow
The company reported a strong operating cash flow of SEK 255 million, benefiting from positive contributions from net working capital.